Showing results (261-270 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|July 28, 2026
Therapeutic outcomes of CAL/BDP PAD-based cream in patients with mild-to-moderate psoriasis: insights from four case reportsAnnunziata Dattola, Andrea Sechi, Luigi Gargiulo, et al.Drugs in Context|August 11, 2026
Topical gene therapy for severe recessive dystrophic epidermolysis bullosa: clinical outcomes and multidisciplinary management in three patients treated with beremagene geperpavec (B-VEC) in Italy - a case seriesMichela Brena, Sophie Guez, Lucia LospallutiDrugs in Context|August 28, 2026
Cerebral folate deficiency, developmental difficulties in autism spectrum disorder and the role of leucovorin: a narrative review of mechanisms and clinical evidenceKrittisak AnurojDrugs in Context|November 19, 2021
New and emerging lipid-modifying drugs to lower LDL cholesterolConstantine E Kosmas, Dafni Pantou, Andreas Sourlas, et al.Drugs in Context|November 13, 2018
Sublingual allergen immunotherapy for respiratory allergy: a systematic reviewCarlos Blanco, Raphaelle Bazire, Laura Argiz, et al.Drugs in Context|November 13, 2018
A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitorsMariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, et al.Drugs in Context|September 14, 2019
From medications to surgery: advances in the treatment of motor complications in Parkinson's diseaseKanae Jennifer Nagao, Neepa J PatelDrugs in Context|September 14, 2019
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited optionsRudolf Hoermann, John E M Midgley, Rolf Larisch, et al.Drugs in Context|January 18, 2021
Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countriesGeorge Kassianos, Ashis Banerjee, Florence Baron-Papillon, et al.Pageof 56